Egnyte Announces New Solution for Clinical Trial Operations
Summary
Egnyte for Life Sciences eTMF is a 21 CFR Part 11 compliant solution that reduces document processing time while maintaining compliance and audit readiness. “In the US alone, the number of registered studies this year has already surpassed the high-water mark set in 2020, and we have not even entered the fourth quarter,” said Ramin Farassat, Chief Product Officer, Egnyte. “Designed to meet the needs of the growing class of emerging and midsize biosciences companies, Egnyte’s eTMF solution will alleviate the data management burdens associated with trial studies, so clinical teams can focus on their core mission – getting safe and effective treatments to market quickly.” • Stay on track with milestones. Built on Egnyte’s leading secure collaboration platform, get full visibility into study milestones, allowing clinical teams to communicate with sites to stick to timelines. More than 16,000 organizations trust Egnyte to reduce risks and IT complexity, prevent ransomware and IP theft, and boost employee productivity on any app, any cloud, anywhere.
